Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Revenue (2016 - 2024)

vTv Therapeutics' Revenue history spans 10 years, with the latest figure at $17000.0 for Q4 2024.

  • For Q4 2024, Revenue changed N/A year-over-year to $17000.0; the TTM value through Sep 2025 reached $17000.0, down 98.3%, while the annual FY2024 figure was $1.0 million, N/A changed from the prior year.
  • Revenue for Q4 2024 was $17000.0 at vTv Therapeutics, down from $1.0 million in the prior quarter.
  • Across five years, Revenue topped out at $6.4 million in Q4 2020 and bottomed at $7000.0 in Q3 2020.
  • The 4-year median for Revenue is $13000.0 (2021), against an average of $1.1 million.
  • The largest annual shift saw Revenue skyrocketed 91314.29% in 2020 before it tumbled 99.86% in 2021.
  • A 4-year view of Revenue shows it stood at $6.4 million in 2020, then crashed by 99.86% to $9000.0 in 2021, then changed by 0.0% to $9000.0 in 2022, then surged by 88.89% to $17000.0 in 2024.
  • Per Business Quant, the three most recent readings for VTVT's Revenue are $17000.0 (Q4 2024), $1.0 million (Q1 2024), and $9000.0 (Q4 2022).